Skip to main content
    N

    Nektar Therapeutics (NKTR)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $35.91
    -0.53 (-1.45%)

    Market Cap: $1.25B

    Last updated: Nov 17, 2026 at 4:33 PM ET

    Nektar Therapeutics (NKTR) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Nektar Therapeutics (NKTR) has a latest price of $35.91 on Nov 17, 2026, 67.1% below its 52-week high of $109.00. Its price fell 36.6% over the past 12 months. The month-end price fell 79.1% over the 10 years through Oct 2026, a compound annual decline of 14.5%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $1,593.10 in Mar 2018 and its lowest $7.03 in Oct 2023, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart NKTR with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for NKTR.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 52.8%, and over 6 months it fell 46.9%. The month-end price rose 452.8% over the 3 years through Oct 2026, a compound annual rate of 76.8%.

    PeriodChange
    1 month-2.0%
    3 months-52.8%
    6 months-46.9%
    12 months-36.6%
    12 months, with dividends-36.6%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+452.8%+76.8%
    5 years-82.9%-29.8%
    10 years-79.1%-14.5%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2017, when the price rose 386.7%, and its weakest was 2022, when it fell 83.3%.

    YearCloseChange
    2026 through Oct 2026$38.87-8.1%
    2025$42.28+203.2%
    2024$13.94+64.6%
    2023$8.47-75.0%
    2022$33.88-83.3%
    2021$202.55-20.5%
    2020$254.87-21.3%
    2019$323.69-34.3%
    2018$492.80-45.0%
    2017$895.35+386.7%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 23.5% below its 50-day average of $46.93 and 44.8% below its 200-day average of $65.04.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$35.91
    52-week high$109.00-67.1%
    52-week low$33.40+7.5%
    50-day average$46.93-23.5%
    200-day average$65.04-44.8%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 73.2%.

    MeasureValue
    1-year beta1.06
    Largest fall, 1 year-64.3%
    Largest fall, 3 years-73.2%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About NKTR

    What is NKTR's 1-year price change?

    Nektar Therapeutics's price fell 36.6% over the past 12 months. With dividends included, the 12-month total return was -36.6%.

    What is NKTR's 5-year price change?

    Nektar Therapeutics's month-end price fell 82.9% over the 5 years through Oct 2026, a compound annual decline of 29.8%. These figures leave out dividends.

    What is NKTR's 52-week high and low?

    Nektar Therapeutics's 52-week high is $109.00 and its 52-week low is $33.40. Its latest price of $35.91 on Nov 17, 2026 is 67.1% below the high.

    What is NKTR's beta?

    Nektar Therapeutics's 1-year beta against the S&P 500 is 1.06, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 64.3%.

    Is the NKTR chart free?

    Yes. Advanced Charting for NKTR is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.